Search

41. Oral immunotherapy and Viaskin Peanut for peanut allergy: effectiveness and value : final evidence report

Author(s):

Tice, Jeffrey A., author
Herron-Smith, Serina, author
Tsiao, Emily, author
Chapman, Rick M., author
Zaim, Remziye, author
Segel, Celia, author
Rind, David, author
Pearson, Steven D., author
Guzauskas, Greg, author
Hansen, Ryan N., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, July 10, 2019

Subject(s):

Immunotherapy
Peanut Hypersensitivity
United States

42. Targeted immune modulators for ulcerative colitis: effectiveness and value : final evidence report and meeting summary

Author(s):

Ollendorf, Daniel A., author
Bloudek, Lisa, author
Carlson, Josh J., author
Pandey, Rajshree, author
Fazioli, Katherine, author
Chapman, Rick M., author
Bradt, Pamela, author
Pearson, Steven D., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, October 16, 2020

Subject(s):

Colitis, Ulcerative -- drug therapy
Immune System -- drug effects
United States

43. AMX0035 and oral edaravone for amyotrophic lateral sclerosis: final evidence report

Author(s):

Makam, Anil N., author
Nikitin, Dmitriy, author
Richardson, Marina, author
Mohammed, Rasheed, author
McKenna, Avery, author
Pearson, Steven D., author
Rind, David M., author
Suh, Kangho, author
Carlson, Josh J., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, September 13, 2022

Subject(s):

Amyotrophic Lateral Sclerosis -- drug therapy
Drug Therapy, Combination
Edaravone -- therapeutic use
Phenylbutyrates -- therapeutic use
United States

44. Novel agents to prevent chemotherapy-induced neutropenia and other myelosuppressive effects: revised evidence report

Author(s):

Tice, Jeffrey A., author
McKenna, Avery, author
Herce-Hagiwara, Belén, author
Moradi, Ashton, author
Pearson, Steven D., author
Ollendorf, Daniel A., author
Bloudek, Lisa, author
Carlson, Josh J., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 17, 2022

Subject(s):

Antineoplastic Agents -- adverse effects
Chemotherapy-Induced Febrile Neutropenia -- drug therapy
Chemotherapy-Induced Febrile Neutropenia -- prevention & control
Neutropenia -- drug therapy
Neutropenia -- prevention & control
United States

45. Betibeglogene autotemcel for beta thalassemia: effectiveness and value : final evidence report

Author(s):

Beaudoin, Francesca L., author
Richardson, Marina, author
Synnott, Patricia G., author
Lancaster, Victoria, author
Fluetsch, Noemi, author
Herce-Hagiwara, Belén, author
Campbell, Jon D., author
Pearson, Steven D., author
Rind, David M., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, July 19, 2022

Subject(s):

beta-Thalassemia -- therapy
Biological Products -- therapeutic use
Genetic Therapy
United States

46. Special assessment of outpatient treatments for COVID-19: final evidence report and meeting summary

Author(s):

Yeung, Kai, 1981- author
Whittington, Melanie D., author
Beinfeld, Molly, author
Mohammed, Rasheed, author
Wright, Abigail, (Of Institute for Clinical and Economic Review), author
Nhan, Emily, author
Fluetsch, Noemi, author
Richardson, Marina, (Of Institute for Clinical and Economic Review), author
Pearson, Steven D., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, May 10, 2022

Subject(s):

Ambulatory Care
COVID-19 Drug Treatment
Home Infusion Therapy
United States

47. Medications for obesity management: effectiveness and value : final evidence report

Author(s):

Atlas, Steven J., author
Beinfeld, Molly, author
Lancaster, Victoria, author
Nhan, Emily, author
Moradi, Ashton, author
Rind, David M., author
Pearson, Steven D., author
Beaudoin, Francesca L., author
Kim, Kibum, author
Lien, Pei-Wen, author
Shah, Kanya, author
Touchette, Daniel R., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, October 20, 2022

Subject(s):

Bupropion
Glucagon-Like Peptide-1 Receptor Agonists
Liraglutide
Obesity -- drug therapy
Obesity Management -- methods
Phentermine
United States

48. Tirzepatide for type 2 diabetes: final report

Author(s):

Lin, Grace A., author
Nikitin, Dmitriy, author
Moradi, Ashton, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Campbell, Jon D., author
Brouwer, Elizabeth, author
Chen, Yilin, MPH, author
Hansen, Ryan N., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 15, 2022

Subject(s):

Diabetes Mellitus, Type 2 -- drug therapy
Gastric Inhibitory Polypeptide -- therapeutic use
Hypoglycemic Agents -- therapeutic use
Incretins -- therapeutic use
United States